Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective.

Autor: Blagden, Sarah P., Yu, Ly-Mee, Ellis, Stephanie, Hughes, Helen, Shaaban, Abeer, Fennelly-Barnwell, Jonathan, Lythgoe, Mark P., Cooper, Alison M., Maignen, Francois M., Buckland, Sean W., Kearns, Pamela R., Brown, Louise C., Experimental Cancer Medicine Centres (ECMC) CID trials working group

Publikováno v: British Journal of Cancer; Feb2023, Vol. 128 Issue 3, p474-477, 4p

Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

Autor: Blagden, Sarah P., Billingham, Lucinda, Brown, Louise C., Buckland, Sean W., Cooper, Alison M., Ellis, Stephanie, Fisher, Wendy, Hughes, Helen, Keatley, Debbie A., Maignen, Francois M., Morozov, Alex, Navaie, Will, Pearson, Sarah, Shaaban, Abeer, Wydenbach, Kirsty, Kearns, Pamela R., Abouzeid, Christiane, Ahmed, Rubina, Bailey, Sue, Blewett, Catherine, Campbell, Helen, Cerone, Maria Antonietta, Clack, Glen, Cook, Natalie, Ghiorghiu, Serban, Halford, Sarah, Johnston, Andrew, Kaplan, Rick, Lawson, Anna, Lowe, Emma, Mathews, Jacqueline, Mirabile, Ilaria, Osipenko, Leeza, Patel, Dipak, Potter, Claire, Regan, Aoife, Ricamara, Marivic, Ringrose, Carly, Rodger, Joanne, Sandhu, Gurcharan K., Schiavone, Francesca, Silvester, Julie, Sydes, Matthew R., Weller, Charles, Yiangou, Angeliki

Publikováno v: Blagden, S P, Billingham, L, Brown, L C, Buckland, S W, Cooper, A M, Ellis, S, Fisher, W, Hughes, H, Keatley, D A, Maignen, F M, Morozov, A, Navaie, W, Pearson, S, Shaaban, A, Wydenbach, K, Kearns, P R, Abouzeid, C, Ahmed, R, Bailey, S, Blewett, C, Campbell, H, Cerone, M A, Clack, G, Cook, N, Ghiorghiu, S, Halford, S, Johnston, A, Kaplan, R, Lawson, A, Lowe, E, Mathews, J, Mirabile, I, Osipenko, L, Patel, D, Potter, C, Regan, A, Ricamara, M, Ringrose, C, Rodger, J, Sandhu, G K, Schiavone, F, Silvester, J, Sydes, M R, Weller, C & Yiangou, A 2020, ' Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement ', British Journal of Cancer, vol. 122, no. 4, pp. 473-482 . https://doi.org/10.1038/s41416-019-0653-9
British Journal of Cancer

The traditional cancer drug development pathway is increasingly being superseded by trials that address multiple clinical questions. These are collectively termed Complex Innovative Design (CID) trials. CID trials not only assess the safety and toxic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846940b5843ad1cda6b83f6951fb7836
https://doi.org/10.1038/s41416-019-0653-9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.